Literature DB >> 22926447

Diffusion-weighted imaging in Sydenham's chorea.

Hakan Gumus1, Gulsum Gumus, Huseyin Per, Ali Yikilmaz, Mehmet Canpolat, Gamze Poyrazoglu, Nazmi Narin.   

Abstract

PURPOSE: The purpose of this study was to determine of caudate nucleus changes in diffusion-weighted magnetic resonance imaging.
METHODS: A total of 13 children (four males and nine females) with history of Sydenham's chorea and 13 healthy controls were included in to the study. Diffusion cranial magnetic resonance imaging was performed in all subjects before prednisone treatment. Prednisone (2 mg/kg/day, maximum dose 60 mg/day) was used during 4 weeks and then progressively discontinued (20 % of the initial dose was reduced at each 5 days). Two months later, magnetic resonance imaging was repeated.
RESULTS: Before and after 8 weeks of prednisone treatment, apparent diffusion coefficients (ADCs) were calculated for right and left caudate nucleus. The ADC values were significantly different before treatment and 2 months after imaging. For the left caudate nucleus, ADC values before treatment (0.69 ± 0.038) were significantly lower than after treatment (0.95 ± 0.04). For the right caudate nucleus, ADC values before treatment (0.72 ± 0.06 × 10(-3)) were significantly lower than after treatment (0.93 ± 0.04 × 10(-3)).
CONCLUSIONS: Although cranial and caudate nucleus magnetic resonance imaging findings were normal, the low ADC value findings in our study support the autoimmune inflammation in basal ganglia of Sydenham's chorea.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926447     DOI: 10.1007/s00381-012-1898-2

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  29 in total

1.  Randomized double-blind study with prednisone in Sydenham's chorea.

Authors:  José A Paz; Clovis A A Silva; Maria J Marques-Dias
Journal:  Pediatr Neurol       Date:  2006-04       Impact factor: 3.372

2.  Sydenham's chorea: magnetic resonance imaging of the basal ganglia.

Authors:  J N Giedd; J L Rapoport; M J Kruesi; C Parker; M B Schapiro; A J Allen; H L Leonard; D Kaysen; D P Dickstein; W L Marsh
Journal:  Neurology       Date:  1995-12       Impact factor: 9.910

3.  Corticosteroid treatment in patients with Sydenham's chorea.

Authors:  Judith Barash; Dov Margalith; Abraham Matitiau
Journal:  Pediatr Neurol       Date:  2005-03       Impact factor: 3.372

4.  Childhood acute rheumatic fever in Ankara, Turkey.

Authors:  Sema Ozer; Olgu Hallioğlu; Süheyla Ozkutlu; Alpay Celiker; Dursun Alehan; Tevfik Karagöz
Journal:  Turk J Pediatr       Date:  2005 Apr-Jun       Impact factor: 0.552

5.  [Sydenham's chorea: report of a case treated with carbamazepine with excellent clinical response].

Authors:  Ma M García González; L Mayol Canals; P Villalobos Arévalo; M Vázquez Ruiz; A Cabacas García
Journal:  An Pediatr (Barc)       Date:  2007-01       Impact factor: 1.500

6.  Sydenham's chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens.

Authors:  Ferah Genel; Sertac Arslanoglu; Nedret Uran; Berna Saylan
Journal:  Brain Dev       Date:  2002-03       Impact factor: 1.961

7.  PANDAS: a commentary.

Authors:  Harvey S Singer; Christopher Loiselle
Journal:  J Psychosom Res       Date:  2003-07       Impact factor: 3.006

8.  Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association.

Authors: 
Journal:  JAMA       Date:  1992-10-21       Impact factor: 56.272

9.  Brain MR spectroscopy in children with a history of rheumatic fever with a special emphasis on neuropsychiatric complications.

Authors:  Alpay Alkan; Ramazan Kutlu; Gulendam Kocak; Ahmet Sigirci; Murat Emul; Selda Dogan; Mehmet Aslan; Kaya Sarac; Cengiz Yakinci
Journal:  Eur J Radiol       Date:  2004-03       Impact factor: 3.528

10.  Dyskinesias and associated psychiatric disorders following streptococcal infections.

Authors:  R C Dale; I Heyman; R A H Surtees; A J Church; G Giovannoni; R Goodman; B G R Neville
Journal:  Arch Dis Child       Date:  2004-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.